What do microglia really do in healthy adult brain?
M Augusto-Oliveira, GP Arrifano, A Lopes-Araújo… - Cells, 2019 - mdpi.com
Microglia originate from yolk sac-primitive macrophages and auto-proliferate into adulthood
without replacement by bone marrow-derived circulating cells. In inflammation, stroke …
without replacement by bone marrow-derived circulating cells. In inflammation, stroke …
Recent progress in dendrimer-based nanomedicine development
Y Kim, EJ Park, DH Na - Archives of pharmacal research, 2018 - Springer
Dendrimers offer well-defined nanoarchitectures with spherical shape, high degree of
molecular uniformity, and multiple surface functionalities. Such unique structural properties …
molecular uniformity, and multiple surface functionalities. Such unique structural properties …
Dendrimer nanotherapy for severe COVID-19 attenuates inflammation and neurological injury markers and improves outcomes in a phase2a clinical trial
AM Gusdon, N Faraday, JS Aita, S Kumar… - Science translational …, 2022 - science.org
Hyperinflammation triggered by SARS-CoV-2 is a major cause of disease severity, with
activated macrophages implicated in this response. OP-101, a hydroxyl-polyamidoamine …
activated macrophages implicated in this response. OP-101, a hydroxyl-polyamidoamine …
[HTML][HTML] Targeting mitochondrial dysfunction and oxidative stress in activated microglia using dendrimer-based therapeutics
Mitochondrial oxidative stress is associated with many neurodegenerative diseases, such as
traumatic brain injury (TBI). Targeted delivery of antioxidants to mitochondria has failed to …
traumatic brain injury (TBI). Targeted delivery of antioxidants to mitochondria has failed to …
Glycosylation of PAMAM dendrimers significantly improves tumor macrophage targeting and specificity in glioblastoma
Glioblastoma is among the most aggressive forms of cancers, with a median survival of just
15–20 months for patients despite maximum clinical intervention. The majority of …
15–20 months for patients despite maximum clinical intervention. The majority of …
[HTML][HTML] Nanoparticles: A Hope for the Treatment of Inflammation in CNS
FD Zhu, YJ Hu, L Yu, XG Zhou, JM Wu… - Frontiers in …, 2021 - frontiersin.org
Neuroinflammation, an inflammatory response within the central nervous system (CNS), is a
main hallmark of common neurodegenerative diseases, including Alzheimer's disease (AD) …
main hallmark of common neurodegenerative diseases, including Alzheimer's disease (AD) …
Drug studies on Rett syndrome: from bench to bedside
M Gomathi, S Padmapriya, V Balachandar - Journal of autism and …, 2020 - Springer
Drug studies on Rett syndrome (RTT) have drastically increased over the past few decades.
This review aims to provide master data on bench-to-bedside drug studies involving RTT. A …
This review aims to provide master data on bench-to-bedside drug studies involving RTT. A …
Treating Rett syndrome: from mouse models to human therapies
N Vashi, MJ Justice - Mammalian Genome, 2019 - Springer
Rare diseases are very difficult to study mechanistically and to develop therapies for
because of the scarcity of patients. Here, the rare neuro-metabolic disorder Rett syndrome …
because of the scarcity of patients. Here, the rare neuro-metabolic disorder Rett syndrome …
Nanocarrier-based approaches to combat chronic obstructive pulmonary disease
Abnormalities in airway mucus lead to chronic disorders in the pulmonary system such as
asthma, fibrosis and chronic obstructive pulmonary disease (COPD). Among these, COPD is …
asthma, fibrosis and chronic obstructive pulmonary disease (COPD). Among these, COPD is …
Dendrimer-mediated targeted delivery of rapamycin to tumor-associated macrophages improves systemic treatment of glioblastoma
Glioblastoma exhibits high mortality rates due to challenges with drug delivery to the brain
and into solid tumors. This two-pronged barrier necessitates high doses of systemic …
and into solid tumors. This two-pronged barrier necessitates high doses of systemic …